-
Something wrong with this record ?
Two immunoassays for the detection of 2C-B and related hallucinogenic phenethylamines
A. Šuláková, L. Fojtíková, B. Holubová, K. Bártová, O. Lapčík, M. Kuchař,
Language English Country United States
Document type Journal Article, Validation Study
- MeSH
- Dimethoxyphenylethylamine analogs & derivatives chemistry immunology urine MeSH
- Hallucinogens chemistry immunology urine MeSH
- Haptens chemistry immunology MeSH
- Immunoassay economics methods MeSH
- Humans MeSH
- Substance Abuse Detection instrumentation methods MeSH
- Reproducibility of Results MeSH
- Tandem Mass Spectrometry instrumentation methods MeSH
- Illicit Drugs chemistry immunology urine MeSH
- Healthy Volunteers MeSH
- Check Tag
- Humans MeSH
- Male MeSH
- Female MeSH
- Publication type
- Journal Article MeSH
- Validation Study MeSH
INTRODUCTION: The use of new psychoactive substances as drugs of abuse has dramatically increased over the last years. Hallucinogenic phenethylamines gained particular popularity as they have both stimulating and psychedelic effects. Although generally perceived as safe, these illicit drugs pose a serious health risk; they have been linked to cases of severe poisoning or even deaths. Therefore, simple, cost-effective and reliable methods are needed for rapid determination of abused hallucinogens. METHODS: For this purpose, two haptens derived from 2C-H were designed, synthesized and subsequently attached to a carrier protein. Polyclonal antibodies obtained from a rabbit immunized with one of the prepared immunogens were used for the development of two immunoassays. RESULTS: In this study, a lateral flow immunoassay (LFIA) and an enzyme linked immunosorbent assay (ELISA) for the detection of 2C-B and related hallucinogenic phenethylamines in urine were developed. The presented LFIA is primarily suitable for on-site monitoring as it is simple and can provide a visual evidence of 2C-B presence within a few minutes. Its reasonable sensitivity (LODLFIA = 15 ± 7 ng mL-1) allows detection of the drug presence in urine after acute exposure. For greater accuracy, highly sensitive ELISA (LODELISA = 6 ± 3 pg mL-1) is proposed for toxicological quantitative analyses of positive samples captured by the LFIA. DISCUSSION: The comparison of the ELISA with the well-established UHPLC-MS-MS method shows excellent agreement of results, which confirms good potential of the ELISA to be used for routine analyses of 2C-B and related hallucinogenic phenethylamines of both main sub-families.
References provided by Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc19012106
- 003
- CZ-PrNML
- 005
- 20190415130526.0
- 007
- ta
- 008
- 190405s2018 xxu f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1016/j.vascn.2018.11.001 $2 doi
- 035 __
- $a (PubMed)30481558
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a xxu
- 100 1_
- $a Šuláková, Anna $u Department of Chemistry of Natural Compounds, University of Chemistry and Technology Prague, Technická 5, 166 28 Praha 6, Dejvice, Czechia; Forensic Laboratory of Biologically Active Substances, University of Chemistry and Technology Prague, Technická 3, 166 28 Praha 6, Dejvice, Czechia; Department of Experimental Neurobiology, National Institute of Mental Health, Topolová 748, 250 67 Klecany, Czechia. Electronic address: anna.sulakova@nudz.cz.
- 245 10
- $a Two immunoassays for the detection of 2C-B and related hallucinogenic phenethylamines / $c A. Šuláková, L. Fojtíková, B. Holubová, K. Bártová, O. Lapčík, M. Kuchař,
- 520 9_
- $a INTRODUCTION: The use of new psychoactive substances as drugs of abuse has dramatically increased over the last years. Hallucinogenic phenethylamines gained particular popularity as they have both stimulating and psychedelic effects. Although generally perceived as safe, these illicit drugs pose a serious health risk; they have been linked to cases of severe poisoning or even deaths. Therefore, simple, cost-effective and reliable methods are needed for rapid determination of abused hallucinogens. METHODS: For this purpose, two haptens derived from 2C-H were designed, synthesized and subsequently attached to a carrier protein. Polyclonal antibodies obtained from a rabbit immunized with one of the prepared immunogens were used for the development of two immunoassays. RESULTS: In this study, a lateral flow immunoassay (LFIA) and an enzyme linked immunosorbent assay (ELISA) for the detection of 2C-B and related hallucinogenic phenethylamines in urine were developed. The presented LFIA is primarily suitable for on-site monitoring as it is simple and can provide a visual evidence of 2C-B presence within a few minutes. Its reasonable sensitivity (LODLFIA = 15 ± 7 ng mL-1) allows detection of the drug presence in urine after acute exposure. For greater accuracy, highly sensitive ELISA (LODELISA = 6 ± 3 pg mL-1) is proposed for toxicological quantitative analyses of positive samples captured by the LFIA. DISCUSSION: The comparison of the ELISA with the well-established UHPLC-MS-MS method shows excellent agreement of results, which confirms good potential of the ELISA to be used for routine analyses of 2C-B and related hallucinogenic phenethylamines of both main sub-families.
- 650 _2
- $a dimethoxyfenylethylamin $x analogy a deriváty $x chemie $x imunologie $x moč $7 D004118
- 650 _2
- $a ženské pohlaví $7 D005260
- 650 _2
- $a halucinogeny $x chemie $x imunologie $x moč $7 D006213
- 650 _2
- $a hapteny $x chemie $x imunologie $7 D006241
- 650 _2
- $a zdraví dobrovolníci pro lékařské studie $7 D064368
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a imunoanalýza $x ekonomika $x metody $7 D007118
- 650 _2
- $a mužské pohlaví $7 D008297
- 650 _2
- $a reprodukovatelnost výsledků $7 D015203
- 650 _2
- $a zakázané drogy $x chemie $x imunologie $x moč $7 D013287
- 650 _2
- $a odhalování abúzu drog $x přístrojové vybavení $x metody $7 D015813
- 650 _2
- $a tandemová hmotnostní spektrometrie $x přístrojové vybavení $x metody $7 D053719
- 655 _2
- $a časopisecké články $7 D016428
- 655 _2
- $a validační studie $7 D023361
- 700 1_
- $a Fojtíková, Lucie $u Department of Chemistry of Natural Compounds, University of Chemistry and Technology Prague, Technická 5, 166 28 Praha 6, Dejvice, Czechia; Department of Biochemistry and Microbiology, University of Chemistry and Technology Prague, Technická 3, 166 28 Praha 6, Dejvice, Czechia. Electronic address: lucie.fojtikova@vscht.cz.
- 700 1_
- $a Holubová, Barbora $u Department of Biochemistry and Microbiology, University of Chemistry and Technology Prague, Technická 3, 166 28 Praha 6, Dejvice, Czechia. Electronic address: barbora.holubova@vscht.cz.
- 700 1_
- $a Bártová, Kateřina $u Department of Chemistry of Natural Compounds, University of Chemistry and Technology Prague, Technická 5, 166 28 Praha 6, Dejvice, Czechia; Forensic Laboratory of Biologically Active Substances, University of Chemistry and Technology Prague, Technická 3, 166 28 Praha 6, Dejvice, Czechia.
- 700 1_
- $a Lapčík, Oldřich $u Department of Chemistry of Natural Compounds, University of Chemistry and Technology Prague, Technická 5, 166 28 Praha 6, Dejvice, Czechia. Electronic address: oldrich.lapcik@vscht.cz.
- 700 1_
- $a Kuchař, Martin $u Department of Chemistry of Natural Compounds, University of Chemistry and Technology Prague, Technická 5, 166 28 Praha 6, Dejvice, Czechia; Forensic Laboratory of Biologically Active Substances, University of Chemistry and Technology Prague, Technická 3, 166 28 Praha 6, Dejvice, Czechia; Department of Experimental Neurobiology, National Institute of Mental Health, Topolová 748, 250 67 Klecany, Czechia. Electronic address: martin.kuchar@vscht.cz.
- 773 0_
- $w MED00002898 $t Journal of pharmacological and toxicological methods $x 1873-488X $g Roč. 95, č. - (2018), s. 36-46
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/30481558 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y a $z 0
- 990 __
- $a 20190405 $b ABA008
- 991 __
- $a 20190415130549 $b ABA008
- 999 __
- $a ok $b bmc $g 1391416 $s 1050411
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2018 $b 95 $c - $d 36-46 $e 20181124 $i 1873-488X $m Journal of pharmacological and toxicological methods $n J Pharmacol Toxicol Methods $x MED00002898
- LZP __
- $a Pubmed-20190405